Evaluation of ZAR1 and SFRP4 methylation status as potentials biomarkers for diagnosis in cervical cancer: exploratory study phase I.
about
miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line.Antagonizing canonical Wnt signaling pathway by recombinant human sFRP4 purified from E. coli and its implications in cancer therapy.Systematic prediction of target genes and pathways in cervical cancer from microRNA expression data.
P2860
Evaluation of ZAR1 and SFRP4 methylation status as potentials biomarkers for diagnosis in cervical cancer: exploratory study phase I.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Evaluation of ZAR1 and SFRP4 m ...... er: exploratory study phase I.
@en
Evaluation of ZAR1 and SFRP4 m ...... er: exploratory study phase I.
@nl
type
label
Evaluation of ZAR1 and SFRP4 m ...... er: exploratory study phase I.
@en
Evaluation of ZAR1 and SFRP4 m ...... er: exploratory study phase I.
@nl
prefLabel
Evaluation of ZAR1 and SFRP4 m ...... er: exploratory study phase I.
@en
Evaluation of ZAR1 and SFRP4 m ...... er: exploratory study phase I.
@nl
P2093
P2860
P50
P1433
P1476
Evaluation of ZAR1 and SFRP4 m ...... cer: exploratory study phase I
@en
P2093
Alejandra Andana
Priscilla Brebi
Raul Sanchez
Rene Hoffstetter
Tamara Viscarra
P2860
P304
P356
10.3109/1354750X.2013.867535
P577
2014-05-01T00:00:00Z